Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by DJDawgon Dec 02, 2021 10:21pm
540 Views
Post# 34193156

Finance question

Finance question
Hello all,
Congrats on a pretty great day. Since we are in the usual limbo between updates, I had a question about finances:
- I get that the monthly burn is not too bad so we are good to go for the NMIBC trial for now.
- I understand that when the warrants are excercised that that will give the company some more cash. Great.

What I didn't quite understand
- Why did they withdraw the shelf offering option in mid Nov. I'm glad they did as it show confidence but at the same time. Having that in your back pocket makes sense to any company. Why take it away?
- People expected the most recent warrants in Nov to be extended from what I read. But they were not. Isn't extending the warrants a good way to get more cash in the future. So why not do it from the company's perspective.

Maybe the answer is obvious but explain it to my life I'm 5. :)

<< Previous
Bullboard Posts
Next >>